NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/26/2026
Back to search
Official data from USPTO
PENCIL BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
05/26/2026
Classification
Registered
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
10/21/2025
Registration date
05/26/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2026
Last transaction
05/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Macclesfield, Cheshire East, GB
Examiner
LOBO, DEBORAH E
Law office
L90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a zig-zag band and a triangle that represent DNA above the words "PENCIL BIOSCIENCES", wherein the word "PENCIL" is above the word "BIOSCIENCES".
Holders and representatives
Holders
Pencil Biosciences Ltd
Representatives
Scott Locke Dorf Nelson & Zauderer LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparations in the nature of eukaryotic cellscell lines and bio-production cell lines generated using gene editing and gene modifying engineering for scientificlaboratoryclinical or medical research; reagentsenzymesplasmids and assays for scientificgenetic and medical research; molecular biology research toolschemicalbiological and biochemical reagents for research purposes; biological preparations in the nature of separate gene editing components including nucleic acid sequencesRNAmRNArRNAgRNAproteinnucleasenickaseribonucleotide protein (RNP) for use in scientificlaboratoryclinical or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research usein vitro or in vivo use in biotechnology researchfor clinical research and industrial use.
Class 5
Therapeutic and prophylactic pharmaceutical products for use in the treatment of cancergenetic diseasesrare diseasesneurodegenerative diseases and diseases of the immune system; pharmaceutical substances and preparations for use in the treatment of cancergenetic diseasesrare diseasesneurodegenerative diseases and diseases of the immune system; enzymes and enzyme preparations for medical use; biologics in the nature of vectors for the delivery of genes to cellsall for medical purposes; genetically modified cells for medical use; biologics in the nature of vectors for the delivery of genes to cells for medical purposes; cell culture media for medical purposes; biologics in the nature of peptidesproteinsnucleic acidsmodified nucleic acidsribonucleotide proteinmRNA or complexes of these molecules for medical use.
Class 42
Scientificpharmaceutical and medical research and development in the field of gene modificationgene editinggene correctiongene repairgene modulationcell therapycellular modification and gene therapy; genetic engineering servicesbiotechnology research servicesscientific advisory servicesall relating to cell therapy and gene therapy products; consultancy and advisory services relating to the aforesaid services.
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/26/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/07/2026
PUBO
PUBLISHED FOR OPPOSITION
04/07/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/11/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/07/2026
GNRT
NON-FINAL ACTION E-MAILED
03/07/2026
CNRT
NON-FINAL ACTION WRITTEN
03/07/2026
DOCK
ASSIGNED TO EXAMINER
03/06/2026
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/05/2026
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/05/2026
MAFR
APPLICATION FILING RECEIPT MAILED
10/21/2025
NWAP
NEW APPLICATION ENTERED
10/21/2025
Continuous trademark protection
Get notified about every new filing that threatens PENCIL BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.